Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
about
Regulation of membrane permeability by a two-component regulatory system in Pseudomonas aeruginosaCumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients.Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosisDeterminants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.Pseudomonas aeruginosa: resistance to the maxAminoglycoside resistance in Pseudomonas aeruginosa.Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System.Microbial Nanoculture as an Artificial MicronicheEfflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis.History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment.Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Pseudomonas aeruginosa Isolates from Burn Patients.Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients.Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosaAntimicrobial susceptibility differences among mucoid and non-mucoid Pseudomonas aeruginosa isolates.Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.Aerosolizing Lipid Dispersions Enables Antibiotic Transport Across Mimics of the Lung Airway Surface Even in the Presence of Pre-existing Lipid Monolayers.Evaluation of Biofilm Formation and Frequency of Multidrug-resistant and Extended Drug-resistant Strain in Pseudomonas aeruginosa Isolated from Burn Patients in Isfahan.
P2860
Q28492587-F7E42085-640D-4DB7-80FA-C94A3AC4F219Q33267866-EC045FAE-ED54-4A0A-8B5C-DBB9439845D4Q33966881-FD9A5104-4AB3-476A-AE88-FF4C1C5F3B9AQ33983611-37E9933B-6829-426B-8AF7-E0268ECD45EBQ34386310-B5540CBE-F5C1-46BF-8092-0F92DB07E2F7Q35084559-8151532A-3D74-4984-9D62-1BFA8B571810Q36021296-2A460B56-9CFD-4EE0-ADA7-2E7DA6C73225Q36933502-27C4EC13-97D0-411F-9935-0D13EF89FC8BQ37141188-1113C894-F665-41C1-A9FE-E63A621224F5Q37190771-813E89EA-5FD9-48B9-9597-15A55FA45423Q37892898-3268231C-4EF4-40BC-AE95-10471BF80A51Q38644903-54832DA1-2EE6-4D55-A944-903A9251DF1FQ38679855-53B27F6D-FD45-4113-A762-402204BFE95BQ39913368-A2064FBC-9AF1-498F-AB5F-C639657C7AD3Q41129615-7F039A9C-3E21-466D-9B67-1820738FC1FDQ41841534-E05F00B3-FB0E-4315-B1A9-7D09D34D81E7Q42141817-7EE56508-C9BD-4D1E-8919-611B3F08098EQ42246881-EA19E858-19E6-4BB1-B483-8CB26C6E83EBQ42550334-DEA3B3FA-2F12-4294-A4AF-044450E9C42BQ47426647-F5782ED6-6DA2-46A5-816C-B2AB1DB16495Q55059303-E5F49708-0328-4CF0-B0CD-803F698FE968
P2860
Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Activities of tobramycin and s ...... patients with cystic fibrosis.
@ast
Activities of tobramycin and s ...... patients with cystic fibrosis.
@en
type
label
Activities of tobramycin and s ...... patients with cystic fibrosis.
@ast
Activities of tobramycin and s ...... patients with cystic fibrosis.
@en
prefLabel
Activities of tobramycin and s ...... patients with cystic fibrosis.
@ast
Activities of tobramycin and s ...... patients with cystic fibrosis.
@en
P2093
P2860
P921
P1476
Activities of tobramycin and s ...... patients with cystic fibrosis.
@en
P2093
Clausen CR
MacLeod DL
P2860
P304
P407
P577
1999-12-01T00:00:00Z